To further explore whether CIP2A was required for NPC tumor growth in vivo, we conducted xenograft tumor model assays by subcutaneously injecting SUNE-1 cells stably expressing shCIP2A or scrambled control siRNA into the dorsal flank of several mice. This evidence concerns the gene CIP2A and nasopharyngeal carcinoma.